0001562180-23-005105.txt : 20230613 0001562180-23-005105.hdr.sgml : 20230613 20230613162455 ACCESSION NUMBER: 0001562180-23-005105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230609 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alpern Paul L CENTRAL INDEX KEY: 0001888542 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40960 FILM NUMBER: 231011494 MAIL ADDRESS: STREET 1: C/O ARTERIS, INC. STREET 2: 595 MILLICH DR., SUITE 200 CITY: CAMPBELL STATE: CA ZIP: 95008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arteris, Inc. CENTRAL INDEX KEY: 0001667011 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 595 MILLICH DR., SUITE 200 CITY: CAMPBELL STATE: CA ZIP: 95008 BUSINESS PHONE: (408) 470-7300 MAIL ADDRESS: STREET 1: 595 MILLICH DR., SUITE 200 CITY: CAMPBELL STATE: CA ZIP: 95008 4 1 primarydocument.xml PRIMARY DOCUMENT X0407 4 2023-06-09 false 0001667011 Arteris, Inc. AIP 0001888542 Alpern Paul L C/O ARTERIS, INC. 595 MILLICH DR., SUITE 200 CAMPBELL CA 95008 false true false false VP and General Counsel true Common Stock 2023-06-09 4 M false 40000.00 0.60 A 88953.00 D Common Stock 2023-06-09 4 S false 42051.00 7.3344 D 46902.00 D Stock Options (Right to Buy) 0.60 2023-06-09 4 M false 40000.00 0.00 D 2030-07-22 Common Stock 40000.00 20000.00 D Stock Options (Right to Buy) 0.56 2029-10-23 Common Stock 200000.00 200000.00 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. 25% of the total shares shall vest on July 23 2021; thereafter, 1/48th of the total shares shall vest monthly for 3 years. beginning on August 23, 2021. Includes 46,902 restricted stock units. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.55 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares subject to the stock option will vest and become exercisable with respect to 25% of the shares on August 26, 2020 and in 36 substantially equal monthly installments thereafter. /s/ Paul Alpern 2023-06-13